Alivus Life

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE03Q201024
  • NSEID: ALIVUS
  • BSEID: 543322
INR
885.95
15.35 (1.76%)
BSENSE

Dec 05

BSE+NSE Vol: 1.48 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 8.61% vs -6.67% in Sep 2024

stock-summary

Standalone Net Profit

Growth in half year ended Sep 2025 is 21.64% vs -18.64% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 19.62% vs -18.43% in Sep 2024

stock-summary

Interest

Growth in half year ended Sep 2025 is 267.14% vs -12.50% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of Alivus Life With
Markets Mojo
Figures in Cr
Standalone Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,189.83
1,674.62
-484.79
-28.95%
Other Operating Income
0.00
27.20
-27.20
-100.00%
Total Operating income
1,189.83
1,701.82
-511.99
-30.08%
Raw Material Cost
557.94
721.48
-163.54
-22.67%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-38.63
7.93
-46.56
-587.14%
Employee Cost
127.98
210.23
-82.25
-39.12%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
-0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
191.06
407.14
-216.08
-53.07%
Total Expenditure (Excl Depreciation)
838.34
1,346.77
-508.43
-37.75%
Operating Profit (PBDIT) excl Other Income
351.49
355.05
-3.56
-1.00%
Other Income
23.71
21.04
2.67
12.69%
Operating Profit (PBDIT)
375.20
376.09
-0.89
-0.24%
Interest
2.57
30.33
-27.76
-91.53%
Exceptional Items
0.00
-12.16
12.16
100.00%
Gross Profit (PBDT)
372.63
333.60
39.03
11.70%
Depreciation
35.50
80.25
-44.75
-55.76%
Profit Before Tax
337.12
253.35
83.77
33.06%
Tax
85.56
63.26
22.30
35.25%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
251.56
190.10
61.46
32.33%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
251.56
190.10
61.46
32.33%
Equity Capital
25.43
24.26
1.17
4.82%
Face Value
2.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
19.78
7.84
11.94
152.30%
Diluted Earnings per share
20.51
7.84
12.67
161.61%
Operating Profit Margin (Excl OI)
29.54%
21.20%
0.00
8.34%
Gross Profit Margin
31.32%
19.92%
0.00
11.40%
PAT Margin
21.14%
11.35%
0.00
9.79%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 1,189.83 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 8.61% vs -6.67% in Sep 2024

Half Yearly - Standalone Net Profit
Standalone Net Profit 251.56 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 21.64% vs -18.64% in Sep 2024

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 351.49 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 19.62% vs -18.43% in Sep 2024

Half Yearly - Interest
Interest 2.57 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 267.14% vs -12.50% in Sep 2024

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 29.54%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has improved from Sep 2024